"Central Care Cancer Center provides professional expertise, the latest cancer fighting technology, and unparalleled support services across the states of Kansas and Missouri. Central Care Cancer Center provides medical oncology, chemotherapy, hematology and radiation therapy services."

During the past decade, Central Care Cancer Center - Garden City conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 16 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 16 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Care Cancer Center - Garden City" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Care Cancer Center - Garden City" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Central Care Cancer Center - Garden City" are "Invasive Breast Carcinoma" (9 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials), "Stage IIIA Breast Cancer" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (5 trials). Many other conditions were trialed in "Central Care Cancer Center - Garden City" in a lesser frequency.

Most popular intervention types in "Central Care Cancer Center - Garden City" are "Drug" (96 trials), "Other" (66 trials), "Biological" (59 trials), "Procedure" (51 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (30 trials), "Quality-of-Life Assessment" (30 trials), "Computed Tomography" (28 trials), "Laboratory Biomarker Analysis" (25 trials) and "Nivolumab" (24 trials). Other intervention names were less common.

The vast majority of trials in "Central Care Cancer Center - Garden City" are 115 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Central Care Cancer Center - Garden City". undefined are not yet recruiting, 62 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Central Care Cancer Center - Garden City, 6 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Central Care Cancer Center - Garden City, 2 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".